IHC 2023 presentations
IHS members have access to the presentations given during the 21st IHC held in Seoul, Republic of Korea, in September 2023.
Click the links below to watch the videos.
A selection of presentations are available for non-members, including Practice Recommendations for migraine treatment, IHC 2023 basic and clinical science highlights, Research priorities for headache – NINDS and funding, IASP-IHS session – Orofacial pain and headache, International Forum for Headache Nurses: Utilising headache nurses globally in reducing the global burden of headache, Headache Trainees Excellence Tournament, IHS-GPAC Summit, and Cluster Headache Award 2023.
-
Opening Ceremony and Presidential Symposium
Welcome to Seoul
Introduction to the programme
Presidential Symposium: Endocannabinoid and paracannabinoid modulation of migraine-related pain – Daniele Piomelli -
IHS Special Lecture
What do we know about sex-related differences on headaches – Gisela Terwindt -
Cephalalgia Award Lecture
Salivary CGRP can monitor the different migraine phases: CGRP (in)dependent attacks – Patricia Pozo-Rosich -
Special Event – IHS Practice Recommendations for migraine treatment (Open access)
Chair: Messoud Ashina
The idea – Cristina Tassorelli
The output – Francesca Puledda -
What’s next after CGRP
Chair: Messoud Ashina
Novel paths beyond neuropeptides – Greg Dussor
Human model of migraine: future targets – Messoud Ashina
Emerging new anti-migraine targets from basic research – Andrew Russo -
Current research in biomarkers for headaches
Chair: Patricia Pozo-Rosich
Is there any soluble biomarker for primary headaches? – Patricia Pozo-Rosich
Electrophysiological biomarkers for headaches: the search for the holy grail – Gianluca Coppola
A biomarker potential of functional brain connectivity – Catherine D. Chong -
Headaches associated with vascular events
Chair: Simona Sacco
Is migraine a cerebrovascular disorder? – Cenk Ayata
The subtle link between the heart and the brain – Simona Sacco
Update on reversible cerebral vasoconstriction syndrome – Shuu-Jiun Wang -
CGRP antagonists 5 years in – what have we learned
Chair: Rami Burstein
Brain functions altered by peripherally acting CGRP inhibitors: lessons learned from prodromes and triggers – Rami Burstein
Emerging information on similarities and differences between CGRP antibody and small molecule treatments – Antoinette Maassen van den Brink
Clinical management and side effect profiles of different CGRP antagonists – Hans Christoph Diener -
Emerging technologies in headaches
Chair: William Renthal
Advances in omics technology: Implications for research & treatment – William Renthal
Diagnostic and prognostic utilization of artificial intelligence/machine learning algorithms – Bo-Yong Park
Smarter methodologies for monitoring headache disorders – Richard Lipton -
Emerging mechanisms and treatments in post-traumatic headache
Chair: Todd Schwedt
Potential treatment insights from PTH models – Dan Levy
The role of MRI in the understanding and diagnosis of post-traumatic headache – Todd Schwedt
Treatment of post-traumatic headache – Faisal Mohammed Amin -
The morphofunction of migraine brain
Chair: Fu-Jung Hsiao
Electrophysiological changes along the migraine cycle: the electrical dance – Fu-Jung Hsiao
Assigning role to brain areas based on functional and molecular imaging studies in migraine patients – Alexandre Da Silva
Neuroimaging correlates of electrophysiological findings – Marco Lisicki -
Beyond the binary – exploring the impact of diversity on headache science
Chair: Gisela Terwindt
Why attention to diversity is crucial in clinical practice and research – two illustrative examples (example of sex difference in triptan response and osmophobia not being in the IHCD-3 criteria) – Gisela Terwindt
Diversity in science, what have we accomplished and what are we striving for (results of survey on carrier barriers and harassment will be discussed) – Irene de Boer
Prevalence Rates of primary headache disorders and evaluation and treatment patterns among Korean Neurologists – Soo Jin Cho
Lessons learned while going up – how to take control of your career and have a life! – Dawn Buse -
Does real-world evidence have a role in headache medicine
Chairs: Patricia Pozo-Rosich
Debate
Editor’s view – PRO Paolo Martelletti; CON Amy Gelfand
Clinician’s view: PRO Marta Torres-Ferrus; CON Dimos Mitsikostas -
Phenotypes of trigeminovascular activation – the grey areas
Chair: KC Brennan
Tension type headache or migraine? – Sait Ashina
Sensory amplification and trigeminal activation – KC Brennan
Pericranial muscle involvement in headaches – Anna Andreou -
Internal and environmental pressure headaches
Chair: Jan Hoffmann
Update on headache attributed to idiopathic intracranial hypertension – Jan Hoffmann
Update on headache attributed spontaneous intracranial hypotension – Henrik Schytz
Headaches related to altitude changes – Gregor Brössner -
Challenging case discussions
Chair: Maria Teresa Goicochea
Diagnostic challenges in trigeminal neuralgia and atypical facial pain – Giorgio Lambru
Management difficulties in medication overuse headache – Hong-Kyun Park
Vestibular migraine or benign paroxysmal vertigo? – Ji-Ying Zhou -
The plethora of headache comorbidity – basic science and clinical aspects
Chair: Aynur Özge
Metabolic & lipid dysregulation in headaches – Jelena Pavlović
Musculoskeletal disorders and primary headaches – Debora Bevilaqua-Grossi
Psychiatric comorbidities in children and adults – Aynur Özge -
Update on trigeminal autonomic cephalalgias
Chair: Andrea Carmine Belin
Recent developments in the genetics of cluster headache – Andrea Carmine Belin
Recent progress in neuroimaging of TACs – Fu-Chi Yang
Update on paediatric cluster headache – Laura Papetti -
The inflammable brain – from the immune system to the meninges
Chair: Hayrunnisa Bolay
Interaction of calvarial immune system with meninges and the brain – Alejandro Labastida-Ramirez
Cross talk between nociception and immune system – Kenta Maruyama
What is the role of the inflammatory response in headache – Hayrunnisa Bolay -
Complementary medicine for headaches – the colours of mind
Chair: Rebecca Wells
How do meditation and mindfulness help in headaches? – Rebecca Wells
Is there room and evidence for complimentary therapies in children and adolescents – Jennifer McVige -
How do you treat migraine pain without monoclonal antibodies and triptans?
Chair: Derya Uluduz
Emergency setting of headache management Calixte Kuate
Preventive medication: Low budget solutions Mansoureh Togha
Peripheral nerve blocks in headache practice Derya Uluduz -
Additional options when classic or new drugs are not effective or not available
Chair: Fayyaz Ahmed
Blocks, infusions, new delivery modalities and new associations – Stephen Silberstein
Update on neuro-modulatory device use in headaches – Fayyaz Ahmed -
Pathophysiology of cluster headache: not just the hypothalamus
Chair: Arne May
The enigmatic role of the hypothalamus: does it initiate and end the attack? – Arne May
What is the significance of the involvement of the mesolimbic system? – Tzu-Hsien Lai
Is the cluster headache a pathology of the glymphatic system? – Ho-Joon Lee -
Tension-type headache: is it really the Cinderella of headaches?
Chair: Amr Hassan
The global prevalence and the burden of tension-type headache – Christian Lampl
The brain networks and the tension-type headache – Wei-Ta Chen
Non-pharmacological treatments: is there anything useful? – Amr Hassan -
The science behind migraine and neuropsychiatric comorbidity
Chair: Dawn Buse
Sleep-related disorders and migraine – Mamoru Shibata
Mood disorders and migraine – Dawn Buse
Cognitive dysfunction and migraine – Raquel Gil-Gouveia -
Chronic cluster headache management
Chair: Teshamae Monteith
Diagnostic challenges and treatment options in chronic cluster headache – Soo-Jin Cho
What to do with the real refractory cases with chronic cluster headache? – Teshamae Monteith -
Gastrointestinal system and headaches
Chair: Shengyuan Yu
Microbiota: We are what we eat – Dongeun Yong
Novel mechanisms of migraine food triggers and analgesic overuse – Doga Vuralli -
Reducing disparities in headache healthcare
Chair: Augustina Charway-Felli
Variability of drugs availability in the different geographic regions – Maria Teresa Goicochea
What are the barriers and possible solutions? – Morris Levin -
The scientific tales – how to create a career in the headache world
Chair: Cristina Tassorelli
From the animal model to man – Peter Goadsby
Let’s start a career in headache research! – Mi Ji Lee -
Debate: Acupuncture is as effective as oral preventive treatment in tension-type headache and migraine
Chair: Fayyaz Ahmed
Pro – Bronwyn Jenkins
Con – Yen-Feng Wang -
Debate – Do we need to treat paediatric headaches with medications
Chair: Aynur Özge
Pro – Ishaq Abu Arafeh
Con – Tal Eidlitz Markus -
Oral Communications 1
Oral presentations from submitted abstracts
-
Oral Communications 2
Oral presentations from submitted abstracts
-
Oral Communications 3
Oral presentations from submitted abstracts
-
Late Breaking Abstracts 1
Oral presentations from submitted abstracts
-
Late Breaking Abstracts 2
Oral presentations from submitted abstracts
-
Research Priorities for Headache – NINDS and funding (Open access)
Chair: Peter Goadsby and Cristina Tassorelli
Introduction to NINDS (AHS/IHS Research Priorities – Todd Schwedt
Where we stand – Aminah Pradhan
Funding opportunities – Smriti Iyengar -
IASP-IHS session – Orofacial pain and headache (Open access)
Chair: Lars Bendtsen
Comorbid presentation of TMD with primary headache and facial neuropathic pain disorders – Donald Nixdorf
Update on management of trigeminal neuralgia – what should the clinician know? Important lessons learnt from recent research – Lars Bendtsen
The patient’s journey through trigeminal neuralgia – Joanna Zakrzewska -
International Forum for Headache Nurses: Utilising headache nurses globally in reducing the global burden of headache (Open access)
Chair: Esther Thomkins
The burden of headache – Gøril Gravdahl
Headache are in Japan – Kaori Tabata
The role of headache nurses in reducing the burden of headache – Jennifer Trouerbach-Kraan
Pushing the boundaries of headache nursing in efficient delivery of headache care – Susie Lagrata -
Headache Trainees Excellence Tournament (Open access)
Six young researchers and clinicians give a short presentation and compete to be voted the best in basic science and clinical science categories -
IHS-GPAC Summit (Open access)
Chairs: Olivia Begasse de Dhaem and Tina Charway-Felli
IHS-GPAC, a coalition of leading patient advocates, patient advocacy organizations, headache, neurology, and pain professional societies, regulatory agencies, and industry partners, was formed in 2017 after an initial summit at IHC Vancouver. A second summit was held in 2019 at IHC Dublin. IHS-GPAC participated in the patient advocacy day at IHC Berlin in 2021. Two white papers have been published and the coalition has led a highly successful advocacy initiative in the workplace with Fujitsu in Tokyo, Japan -
Cluster Headache Award 2023 (Open access)
Chair: Roberto De Icco
Mi Ji Lee – awarded the ‘Giuseppe Nappi Cluster Headache Award 2023’ -
Basic Science, Neuroimaging and Clinical Physiology and Clinical Science Highlights (Open access)
Presented by KC Brennan, Gianluca Coppola and Hayrunnissa Bolay, IHC 2023 Scientific Programme Chairs